- Home
- RLAY vs SGML Comparison
RLAY vs SGML Comparison
Compare RLAY & SGML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLAY | SGML |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | RLAY | SGML |
|---|---|---|
| Price | $7.81 | $15.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $16.00 | $14.50 |
| AVG Volume (30 Days) | 2.3M | ★ 4.1M |
| Earning Date | 02-25-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $8,355,000.00 | ★ $138,959,151.00 |
| Revenue This Year | $20.47 | $52.45 |
| Revenue Next Year | N/A | $22.13 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.78 | $4.25 |
| 52 Week High | $9.04 | $16.60 |
Technical Indicators
Market Signals| Indicator | RLAY | SGML |
|---|---|---|
| Relative Strength Index (RSI) | 47.13 | 62.77 |
| Support Level | $7.85 | $12.83 |
| Resistance Level | $8.66 | $16.60 |
| Average True Range (ATR) | 0.41 | 1.26 |
| MACD | -0.11 | -0.04 |
| Stochastic Oscillator | 18.41 | 73.85 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About SGML Sigma Lithium Corporation
Sigma Lithium Corp together with its direct and indirect subsidiaries, is a commercial producer of lithium concentrate. It holds a 100% interest in four mineral properties: Grota do Cirilo, Sao Jose, Santa Clara, and Genipapo, located in the municipalities of Aracuai and Itinga, in the Vale do Jequitinhonha region in the State of Minas Gerais, Brazil.